| Keywords: |
survival rate; review; cisplatin; treatment planning; combined modality therapy; cancer staging; cancer diagnosis; cancer incidence; lymph node dissection; neoplasm staging; diagnostic accuracy; sensitivity and specificity; lymph node excision; metastasis; computer assisted tomography; neoplasm recurrence, local; antineoplastic combined chemotherapy protocols; tumor markers, biological; risk factors; tomography, x-ray computed; tumor marker; cancer mortality; diagnosis; testis tumor; testicular neoplasms; predictive value of tests; remission induction; reliability; orchiectomy; germ cell tumor; clinical trials; non seminomatous germinoma; chorionic gonadotropin; retroperitoneal space; lymphangiography; germinoma; alpha-fetoproteins; prognosis; human; male; priority journal
|
